Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · IEX Real-Time Price · USD
5.45
-0.02 (-0.37%)
Apr 25, 2024, 4:00 PM EDT - Market closed

Monte Rosa Therapeutics Statistics

Total Valuation

GLUE has a market cap or net worth of $273.34 million. The enterprise value is $77.44 million.

Market Cap 273.34M
Enterprise Value 77.44M

Important Dates

The next estimated earnings date is Thursday, May 9, 2024, before market open.

Earnings Date May 9, 2024
Ex-Dividend Date n/a

Share Statistics

GLUE has 50.15 million shares outstanding. The number of shares has increased by 8.83% in one year.

Shares Outstanding 50.15M
Shares Change (YoY) +8.83%
Shares Change (QoQ) +14.40%
Owned by Insiders (%) 0.86%
Owned by Institutions (%) 98.54%
Float 23.65M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS 46.19
PB Ratio 1.47
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.07, with a Debt / Equity ratio of 0.26.

Current Ratio 5.07
Quick Ratio 5.00
Debt / Equity 0.26
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -65.90% and return on invested capital (ROIC) is -63.61%.

Return on Equity (ROE) -65.90%
Return on Assets (ROA) -47.30%
Return on Capital (ROIC) -63.61%
Revenue Per Employee n/a
Profits Per Employee -$1.02M
Employee Count 133
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, GLUE has paid $338,000 in taxes.

Income Tax 338,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +13.79% in the last 52 weeks. The beta is 1.45, so GLUE's price volatility has been higher than the market average.

Beta (1Y) 1.45
52-Week Price Change +13.79%
50-Day Moving Average 6.43
200-Day Moving Average 5.49
Relative Strength Index (RSI) 35.19
Average Volume (30 Days) 134,538

Short Selling Information

The latest short interest is 1.68 million, so 3.36% of the outstanding shares have been sold short.

Short Interest 1.68M
Short Previous Month 1.83M
Short % of Shares Out 3.36%
Short % of Float 7.12%
Short Ratio (days to cover) 11.37

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -143.31M
Pretax Income -135.01M
Net Income -135.35M
EBITDA -128.79M
EBIT -135.01M
Earnings Per Share (EPS) -$2.63
Full Income Statement

Balance Sheet

The company has $232.41 million in cash and $46.04 million in debt, giving a net cash position of $186.37 million or $3.72 per share.

Cash & Cash Equivalents 232.41M
Total Debt 46.04M
Net Cash 186.37M
Net Cash Per Share $3.72
Equity / Book Value 179.25M
Book Value Per Share 3.57
Working Capital 189.62M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$43.80 million and capital expenditures -$18.98 million, giving a free cash flow of -$62.78 million.

Operating Cash Flow -43.80M
Capital Expenditures -18.98M
Free Cash Flow -62.78M
FCF Per Share -$1.22
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

GLUE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -8.83%
Shareholder Yield -8.83%
Earnings Yield -51.31%
FCF Yield -23.80%

Analyst Forecast

The average price target for GLUE is $11.00, which is 101.84% higher than the current price. The consensus rating is "Buy".

Price Target $11.00
Price Target Difference 101.84%
Analyst Consensus Buy
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2